OLAIolanzapineoral olanzapineschizophreniaFrench National Agency for Medicinespublic psychiatric hospital
…Background and Importance Long-acting injectable olanzapine (OLAI) is prescribed to stabilised schizophrenia patients previously …
10,506articles mentioning drugs
58,393drug mentions
9,496distinct drugs extracted
0%of mentions human-reviewed
All extracted drugs
Showing 541–600 of 9,496, ordered by supporting articles. Choose a drug to see its evidence.
N-Acetyl Cysteine7PPIs7Streptozotocin7fondaparinux7high-dose corticosteroids7hydroxyurea7naltrexone7tyrosine kinase inhibitors7vaccines7SGLT-2i6Glipizide6BLV6Varenicline6Camrelizumab6Cancer Drugs6Benzene6Doxy-PEP6SGLT-2is6Aprepitant6DEX6Dostarlimab6T-DXd6Azacitidine6Esketamine6NAC6Fidaxomicin6ITM6Minocycline6N-acetylcysteine6pMDIs6NBCA6Clofazimine6Filgotinib6Ravulizumab6Atomoxetine6Methylphenidate6amoxicillin-clavulanate6Acetylcysteine6Triamcinolone6anti-PD16Nitrous oxide6Octreotide6injectate6IL-1β6Lenalidomide6OAC6Venetoclax6antihypertensive drugs6n-BCA6Anti-TNF6Golimumab6Placebo6aripiprazole6b/tsDMARDs6Lansoprazole6MDPV6Mitomycin C6Nalbuphine6PCSK9 inhibitors6Sodium-Glucose Co-Transporter 2 Inhibitors6
Articles mentioning drugs
10,506 articles · page 136 of 876morphinedexketoprofenparacetamolomeprazoletertiary care hospital
…hine, omeprazole and dexketoprofen. Justification rates varied: morphine 1% ampoules (54.54%), paracetamol 1 g tablets (31.43%), omepraz…
amitriptyline
…s showed faster drug release. The tablets containing commercial amitriptyline tablets showed a slower dissolution profile compared to the equ…
AmoxicillinMycophenolate mofetilValganciclovirErythromycinLinezolidAzithromycinAmoxicillin–clavulanic acidpaediatrics
…armacopoeia.Results Seven out of 13 formulations were selected: Amoxicillin 250 mg/5 mL, Amoxicillin–clavulanic acid 100 mg/mL–12.5 mg/mL, …
piflufolastatenzalutamideapalutamidecholineprostate cancerradical prostatectomycurative radiotherapyStereotactic Body Radiation TherapyCentral Pharmacy and Therapeutics Commission
…progression, persistence, or recurrence and were candidates for piflufolastat PET per Central Pharmacy and Therapeutics Commission protocol. …
amoxicillinlevofloxacinsulfamethoxazole/trimethoprimcotrimoxazolerifampicinapixabanosteomyelitisendocarditisabscesseslong-term antibiotic therapies+2 more
…re sulfamethoxazole/trimethoprim (24%), levofloxacin (20%), and amoxicillin (19%). A total of 21 pharmaceutical interventions (PIs) were pe…
FenfluraminecannabidiolLennox–Gastaut syndromeDravet syndrometertiary children’s hospitalLGSDS
…nd epileptic encephalopathies with limited therapeutic options. Fenfluramine has shown efficacy in DS and LGS, but evidence in other epilept…
evolocumabalirocumabPCSK9iezetimibebempedoic acidhypercholesterolaemiatertiary care hospital
…s with hypercholesterolaemia treated with PCSK9i (alirocumab or evolocumab).To assess the acceptance rate of the interventions.Material an…
bevacizumabTAStrifluridine/tipiracilBEVColorectal cancermCRCEastern Cooperative Oncology Group
…remains uncertain.Therapy with trifluridine/tipiracil (TAS) and bevacizumab (TAS+BEV) has been evaluated in phase III SUNLIGHT trial, demon…
secukinumabadalimumabIL-17Hidradenitis suppurativa (HS)secondary-level hospital
…ey role in HS pathophysiology, making IL-17 inhibitors, such as secukinumab, a therapeutic option.Aim and Objectives To assess the effectiv…
meropenemOXA48CarbapenemsVIMWorld Health Organisationsecondary care hospital
…nt de-escalation, which means 32 (39%) completed treatment with meropenem even though a narrower-spectrum antibiotic was effective.Conclu…
risankizumabvedolizumabinfliximabadalimumabIL-23 inhibitorsrefractory inflammatory bowel diseaseCrohn’s diseaseulcerative colitisinflammatory bowel diseaseperianal disease
…re recorded. At the end of follow-up, two patients continued on risankizumab monotherapy, while three maintained the combination therapy.Con…